Do you know the impact that this silent liver disease could be having on you?

Non-alcoholic steatohepatitis (NASH) is an advanced form of non-alcoholic fatty liver disease that commonly goes undetected and leads to serious consequences such as liver transplant. Explore your NASH clinical research participation options.

Are you in the 5% of US adults who have developed NASH, but don’t know it?

In the early stages of fatty liver disease, there are typically minimal or no symptoms. This allows fatty liver to progress to NASH.

Individuals at greatest risk of developing NASH are those who are obese, have high blood sugar, and high cholesterol.

NASH is the 2nd leading cause of liver transplants in the U.S.

Hear from others who have participated in clinical research.

“I wholeheartedly hope other people will step up and do it, so they have enough people to fully carry this through.”

Penny

Clinical Trial Participant

“I think that people should try to help other islanders by getting this study going, and I think you should do it.”

Mike

Clinical Trial Participant

“People have to step up and be part of the solution.
It’s nothing to be afraid of.”

Kathleen

Clinical Trial Participant

“We need people to participate in studies to be able to get these things out there and get them approved.”

Janet

Clinical Trial Participant

Testimonials provided by trial participants are personal experiences and do not necessarily represent the views of the trial sponsor or Care Access. They are not a substitute for medical advice, and the results of the trial may vary based on individual circumstances. Always consult with your healthcare provider before making any medical decisions.

Do you know the impact that this silent liver disease could be having on you?

Are you in the 5% of US adults who have developed NASH, but don’t know it?

Hear from others who have participated in clinical research.

You can be a part of the future of NASH care